This website uses cookies to enhance the user experience.
D

DRUG DISCOVERY LABORATORY AS974 982 587

Counseling
Limited company
c/o Jo Klaveness Midtåsen 5 1166 OSLO, Norge

DRUG DISCOVERY LABORATORY AS

Keywords

physicalchemicalanalytical testingmaterialsproductsacoustic testingvibration testingcompositionpurityfood hygieneveterinary controlperformance testingtype approvalcertificationclassification

Organization

Chairman of the board
Years since formation
29 years
since Aug 22, 1995
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
50
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2023
1,680,900
NOK
Annual total result 2023
1,015,417
NOK
Total equity 2023
6,517,784
NOK
Last update: Aug 29, 2024

Management

Board

NameRoleShares
Contact Person, Chairman
100 %
directly
Alternate Member-

Others

NameRoleShares
F
FALKEBLIKK 2 AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Contact Person, Chairman
100 %
directly
Last update: Nov 21, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
50
100 %

Shares owned by the DRUG DISCOVERY LABORATORY AS

NameShare classNumber of sharesShare
A
ARCTIC PHARMA AS
Ordinary shares
2,000
2.35 %
S
SCANDIDERMA AS
Ordinary shares
5,000
2.07 %
S
SERCA PHARMACEUTICALS AS
Ordinary shares
2,960
0.41 %
N
NACAMED AS
Ordinary shares
2,079
0.16 %
S
SERODUS AS
NO0010549801
22,377
0.12 %
N
NAVAMEDIC ASA
NO0010205966
14,400
0.08 %
O
OBSERVE MEDICAL ASA
NO0010865009
14,400
< 0.01 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
1,680,900
2,256,500
1,482,359
Annual Total Result
1,015,417
1,429,691
857,318
Total assets
7,042,486
6,363,776
4,506,261
Total liabilities
524,702
861,410
433,586
Total equity
6,517,784
5,502,367
4,072,675

P&L

Year202320222021
Total operating income
1,680,900
2,256,500
1,482,359
Total operating costs
450,775
424,709
390,090
Operating result
1,230,125
1,831,791
1,092,269
Financial income/costs
67,360
-1,142
2,059
Profit before tax
1,297,485
1,830,649
1,094,328
Total tax & extraordinary income/cost
282,068
400,958
237,010
Annual Total Result
1,015,417
1,429,691
857,318

Balance overview

Year202320222021
Total fixed assets
415,902
409,460
414,728
Total current assets
6,626,584
5,954,316
4,091,533
Total assets
7,042,486
6,363,776
4,506,261
Short term debt
524,702
861,410
433,586
Long term debt
0
0
0
Total liabilities
524,702
861,410
433,586
Contributed capital
100,000
100,000
100,000
Retained earnings
6,417,784
5,402,367
3,972,675
Total equity
6,517,784
5,502,367
4,072,675
Total equity and liabilities
7,042,486
6,363,776
4,506,261

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
71
Activity
Architectural and engineering activities; technical testing and analysis
71.2
Main industrial group
Technical testing and analysis
71.20
Industrial group
Technical testing and analysis
71.200
Industrial group
Technical testing and analysis